Loading, Please Wait...

CST: 13/11/2019 11:50:45   

APYX CLASS ACTION ALERT: Hagens Berman Alerts Apyx Medical Corporation (APYX) Investors to Securities Class Action, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm

195 Days ago

SAN FRANCISCO, May 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, with 9 offices in 8 cities around the country and 80 attorneys, alerts investors in Apyx Medical Corporation (NASDAQ: APYX) to the securities class action, Pritchard v. Apyx Medical Corporation et al., No. 8:19-cv-00919, filed in the United States District Court for the Middle District of Florida.

If you purchased or otherwise acquired Apyx Medical securities between August 1, 2018 and April 1, 2019 (the “Class Period”) and suffered significant losses and suffered losses you do not need to sign up to be included in the putative class of investors.  If you suffered losses in excess of $50,000, you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.

If you wish to serve as a lead plaintiff in this class action, you must move the Court no later than June 17, 2019 (the “Lead Plaintiff deadline”).  Contact Hagens Berman immediately for more information about the case and being a lead plaintiff:

https://www.hbsslaw.com/cases/APYX

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

APYX@hbsslaw.com .

According to the complaint, Defendants misled investors during the Class Period by misstating and/or failing to disclose that: (1) the clinical study on the use of J-Plasma for dermal resurfacing did not meet its primary efficacy endpoint; (2) the clinical study did not support the Company’s application for regulatory clearance; and, (3) the Company was unlikely to receive regulatory approval of J-Plasma for dermal resurfacing.

“We’re focused on investors’ losses, certain matters flagged in a recent bearish analyst report, and whether investors may have been misled,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Apyx should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email APYX@hbsslaw.com.

About Hagens Berman
Hagens Berman is a nationwide law firm representing investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes can be found at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

Is your business listed correctly on America’s largest city directory network of 1,000 portals?